Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$8.79 - $14.58 $484,267 - $803,255
-55,093 Reduced 23.99%
174,557 $1.64 Million
Q4 2022

Feb 13, 2023

SELL
$11.49 - $13.65 $293,155 - $348,266
-25,514 Reduced 10.0%
229,650 $2.81 Million
Q3 2022

Nov 10, 2022

BUY
$12.41 - $32.42 $837,401 - $2.19 Million
67,478 Added 35.95%
255,164 $3.17 Million
Q2 2022

Aug 12, 2022

SELL
$19.63 - $26.62 $489,061 - $663,210
-24,914 Reduced 11.72%
187,686 $3.68 Million
Q1 2022

May 13, 2022

BUY
$24.65 - $29.0 $4.88 Million - $5.74 Million
197,800 Added 1336.49%
212,600 $5.55 Million
Q4 2021

Feb 09, 2022

SELL
$27.74 - $34.09 $61.8 Million - $75.9 Million
-2,226,364 Reduced 99.34%
14,800 $420,000
Q3 2021

Nov 12, 2021

SELL
$29.2 - $36.72 $10.5 Million - $13.2 Million
-358,800 Reduced 13.8%
2,241,164 $71.5 Million
Q2 2021

Aug 12, 2021

SELL
$28.76 - $35.98 $4.6 Million - $5.76 Million
-160,100 Reduced 5.8%
2,599,964 $90.2 Million
Q1 2021

May 13, 2021

SELL
$27.85 - $34.49 $4.09 Million - $5.07 Million
-147,000 Reduced 5.06%
2,760,064 $81.3 Million
Q4 2020

Feb 10, 2021

BUY
$27.53 - $33.79 $33.7 Million - $41.3 Million
1,222,564 Added 72.58%
2,907,064 $89.2 Million
Q3 2020

Nov 12, 2020

BUY
$21.1 - $29.13 $33.3 Million - $46 Million
1,579,700 Added 1507.35%
1,684,500 $47 Million
Q2 2020

Aug 12, 2020

BUY
$18.94 - $24.93 $107,958 - $142,101
5,700 Added 5.75%
104,800 $2.25 Million
Q1 2020

May 14, 2020

BUY
$16.68 - $32.25 $1.65 Million - $3.2 Million
99,100 New
99,100 $2.22 Million
Q3 2019

Nov 12, 2019

SELL
$25.62 - $34.96 $47,140 - $64,326
-1,840 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$31.11 - $34.79 $7.13 Million - $7.97 Million
-229,174 Reduced 99.2%
1,840 $62,000
Q1 2019

May 15, 2019

BUY
$29.0 - $32.83 $6.7 Million - $7.58 Million
231,014 New
231,014 $7.41 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Korea Investment Corp Portfolio

Follow Korea Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.